Expert:
Nicholas Pavlidis
University of Ioannina
Ioannina, Greece
Expert:
Florian Lordick
University Hospital Leipzig
Leipzig, Germany
For translation in other languages: https://www.deepl.com/translator
Expert:
Giuseppe Curigliano
European Institute of Oncology
Milan, Italy
Expert:
Giuseppe Curigliano
European Institute of Oncology
Milan, Italy
Expert:
Olivia Pagani
Riviera-Chablais Hospital
Rennaz, Switzerland
Expert:
Giancarlo Pruneri
National Cancer Institute, IRCCS Foundation
Milan, Italy
Expert:
Maria-João Cardoso, Surgeon
Champalimaud Clinical Center
Lisbon, Portugal
For translation in other languages: https://www.deepl.com/translator
CASES
• Hormone receptor-positive, HER2-negative metastatic breast cancer - To what degree should extent of liver disease guide treatment choice? (E. De Meue, A.L. de Matos)
• Triple negative breast cancer (M. Saerens, M. Neves)
• A not-so-sporadic case of breast cancer (M. Tiako Meyo, M. Marta)
• Interruption of endocrine therapy in early breast cancer for pregnancy (S. Pinelas, J. Heseltine)
• Regional Recurrence in Triple Negative Breast Cancer (H. Stedt, A.R. Monteiro)
• An unexpected clinical evolution of ER+/HER2- breast cancer (P. Zagami, S. Ferreira)
Expert:
Olivia Pagani
Riviera-Chablais Hospital
Rennaz, Switzerland
Expert:
Giancarlo Pruneri
National Cancer Institute, IRCCS Foundation
Milan, Italy
For translation in other languages: https://www.deepl.com/translator
CASES
• Early Triple Negative Breast Cancer (F. Gremonprez, G. Nogueira da Costa)
• Advanced breast cancer with complete and durable response with Her2 double blockade (M. Sirico, R. Cunha)
• Heterogeneous HER2+ HR+ metastatic breast cancer, what do we target (the most)? (S. Jeurissen)
• Breast Cancer (M. Leitão, J. Marinho)
• The Sanctuary of HER 2 positive Breast Cancer (D. da Silva Dias, B. Lima)
Expert:
Giuseppe Curigliano
European Institute of Oncology
Milan, Italy
Expert:
Maria-João Cardoso, Surgeon
Champalimaud Clinical Center
Lisbon, Portugal
For translation in other languages: https://www.deepl.com/translator
Expert:
Karim Fizazi
Institut Gustave Roussy
Villejuif, France
Expert:
Karim Fizazi
Institut Gustave Roussy
Villejuif, France
Expert:
Xavier Maldonado
VHIO Vall d'Hebron Institute of Oncology
Barcelona, Spain
Expert:
Ursula Vogl
Cantonal Hospital of Southern Switzerland (EOC)
Bellinzona, Switzerland
Expert:
Bertrand Tombal
University Hospital Saint-Luc
Bruxelles, Belgium
For translation in other languages: https://www.deepl.com/translator
CASES
• Metastatic Testicular Germ Cell Tumor: If at first you don’t succeed… (W. Mohamed, A. Dipasquale)
• Immunotherapy in kidney cancer (L. Ruggieri, C. Mangas)
• Renal Cell Cancer:A Complex Entity Made More Challenging by Treatment Evolution (K. Oualla, C. Bexiga)
• Mr O. P. Divo (B.M. Johannsdottir, D.A. Patanè)
Expert:
Karim Fizazi
Institut Gustave Roussy
Villejuif, France
Expert:
Bertrand Tombal
University Hospital Saint-Luc
Bruxelles, Belgium
For translation in other languages: https://www.deepl.com/translator
CASES
• Do you feel safe? When the PSA is not enough (M. Lucas, L. Scafuri)
• Clinical case: Prostate cancer (R. Steyn, C. Pernaut Sánchez)
• An Unusual Manifestation Of Renal Cell Carcinoma (S. Lopes, C. Moloney)
• Case report: Bladder cancer in the neo-adjuvant setting (A. Kokkalis, A. Vernadou)
Expert:
Xavier Maldonado
VHIO Vall d'Hebron Institute of Oncology
Barcelona, Spain
Expert:
Ursula Vogl
Cantonal Hospital of Southern Switzerland (EOC)
Bellinzona, Switzerland
For translation in other languages: https://www.deepl.com/translator